LINARES E (Empagliflozin (25mg) + Linagliptin (5mg))

Linares-E Tablet is a composite medication designed to assist in regulating blood glucose levels. It is intended for use alongside dietary modifications and physical activity to enhance glycemic control in individuals diagnosed with type 2 diabetes mellitus. This formulation aids the body in effectively utilizing insulin, which contributes to the reduction of blood sugar levels. Administration of Linares-E Tablet can occur at any time, with or without meals, although it is advisable to consistently take it at the same time each day for optimal results. The prescribing physician will determine the appropriate dosage, and it is crucial not to discontinue the medication without consulting a healthcare professional, as this may lead to an increase in blood sugar, potentially resulting in severe complications such as renal impairment and vision loss. This medication is part of a comprehensive management strategy that should also encompass a nutritious diet, consistent exercise, and weight management as directed by a healthcare provider. The most frequently reported side effects associated with this medication include urinary tract infections, nasopharyngitis, and upper respiratory infections. To mitigate the risk of dehydration, it is beneficial to stay well-hydrated while on this medication. Additionally, some individuals may experience fungal infections in the genital region, which can be minimized by practicing good hygiene. Prior to initiation of this medication, it is essential to inform your healthcare provider about any existing kidney or liver issues, urinary tract infections, or concurrent use of diuretics. Pregnant or nursing individuals should seek medical advice before starting this treatment. It is also important to limit alcohol consumption during this treatment, as it may elevate the risk of side effects. Regularly monitoring blood sugar levels is advised during the course of this medication.